ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7,822.18 | -4,483.94 | -1,592.12 | -1,409.05 | -425.49 | -455.35 | -308.86 | -220.12 | -161.70 | -61.37 | -13.80 | -5.64 | |
| 561.83 | 108.10 | 40.45 | 3.45 | 2.93 | 6.46 | 6.26 | 6.04 | 3.53 | 3.46 | 0.48 | 0.00 | |
| – | – | – | – | – | – | – | – | 15.34 | 8.41 | 1.58 | 0.21 | |
| 1,654.12 | -670.73 | -91.69 | 93.29 | 30.11 | -7.44 | -37.33 | -6.51 | -0.60 | 3.61 | -6.89 | 0.46 | |
| 5.14 | 74.87 | 0.00 | 20.96 | 3.19 | 0.46 | 0.00 | 0.56 | 0.34 | 0.00 | 0.00 | 5.64 | |
| 1,039.51 | -158.48 | – | -10.08 | -4.30 | -387.53 | 370.55 | 12.93 | -0.34 | 1.32 | 0.11 | 0.00 | |
| – | – | – | – | – | – | – | – | 0.00 | -40.23 | 8.95 | 1.43 | |
| 14,027.87 | 2,947.23 | 499.09 | 3,350.08 | 762.14 | 541.00 | -37.70 | 319.41 | 44.75 | -17.47 | 10.06 | 9.80 | |
| 7,245.19 | -1,695.19 | -1,093.04 | 2,063.86 | 332.34 | -301.88 | 23.99 | 112.22 | -117.29 | -77.51 | -3.62 | -13.08 | |
| -7,827.32 | -4,558.82 | -1,592.13 | -1,430.01 | -428.68 | -455.81 | -308.86 | -220.68 | -162.04 | -61.37 | -13.80 | -5.64 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.